Ye Wang

Scientist and team leader specializing in CRISPR-based functional genomics and oncology small molecule drug discovery, focused on targeting tumor-intrinsic vulnerabilities. I lead a team of scientists and oversee multiple discovery programs, driving novel target identification, validation, and progression from platform and assay development through hit identification and hit-to-lead. With a track record of independently advancing target proposals while managing parallel workstreams, I bring a strategic, execution-focused approach to building scalable biology platforms, enabling data-driven decisions, and aligning cross-functional efforts to accelerate the development of first-in-class therapeutics